Benzinga | Nov 5, 2020 09:11AM EST

DA Davidson Upgrades Medifast to Buy, Raises Price Target to $205

DA Davidson upgrades Medifast (NYSE:MED) from Neutral to Buy and raises the price target from $180 to $205.